Pregnolia System
DeviceNo intervention is done except for measuring the stiffness of the cervix in pregnant women
NCT Number: NCT02037334
Quantitative information on the biomechanical properties of the ecto-cervix in mid-pregnancy will be compared between women with term vs. preterm delivery. We aim to demonstrate that biomechanical data (ASP and CCI) might complement morphological data (CL) to improve prediction of preterm delivery. It is expected that women with preterm delivery will show stronger weakening of cervical tissue. Aspiration (ASP) and cervical CCI (cervical consistency index) measurements are performed at mid-pregnancy: detection at this time point is useful for therapy and biomechanical modifications are already significant so to enable differentiation by biomechanical measurements (ASP and CCI).
Looking for future studies?
Notify Me18 year–60 year
Female
Observational
University Hospital of Leuven, Leuven, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention is done except for measuring the stiffness of the cervix in pregnant women
Time frame: Measurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum
The biomechanical measurements and morphological data obtained at mid-pregnancy are compared between women with/without preterm delivery and are expected to significantly differ. The diagnostic power for preterm delivery of aspiration, CCI and the other factors will be determined.
David Scheiner
Other
Acronym: Softcervix
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03608995
Biomarkers, Female Urogenital Diseases and Pregnancy Complications
Clermont-Ferrand, France
View Trial DetailsNCT02694679
Body Temperature Changes, Diarrhea
New Haven, Connecticut, United States
View Trial DetailsNCT00340249
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Bethesda, Maryland, United States
View Trial DetailsNCT03344471
Female Urogenital Diseases and Pregnancy Complications, Mental Disorders
Reims, France
View Trial Details